To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
- PMID: 30622307
- PMCID: PMC6370810
- DOI: 10.1038/s41418-018-0261-x
To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
Abstract
Since the discovery and definition of neutrophil extracellular traps (NETs) 14 years ago, numerous characteristics and physiological functions of NETs have been uncovered. Nowadays, the field continues to expand and novel mechanisms that orchestrate formation of NETs, their previously unknown properties, and novel implications in disease continue to emerge. The abundance of available data has also led to some confusion in the NET research community due to contradictory results and divergent scientific concepts, such as pro- and anti-inflammatory roles in pathologic conditions, demarcation from other forms of cell death, or the origin of the DNA that forms the NET scaffold. Here, we present prevailing concepts and state of the science in NET-related research and elaborate on open questions and areas of dispute.
Conflict of interest statement
FA is an inventor on issued patent no. 8,975,033 held by The Johns Hopkins University that covers “Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases” and serves as a consultant for Bristol-Myers Squibb. The other authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
